Rural-urban differences in financial burden among cancer survivors: an analysis of a nationally representative survey

Springer Science and Business Media LLC - Tập 27 - Trang 4779-4786 - 2019
Whitney E. Zahnd1,2, Melinda M. Davis3,4,5, Jason S. Rotter6, Robin C. Vanderpool7, Cynthia K. Perry8, Jackilen Shannon5, Linda K. Ko9,10, Stephanie B. Wheeler6, Cassie L. Odahowski1,11, Paige E. Farris5, Jan M. Eberth1,11,12
1Rural and Minority Health Research Center, Arnold School of Public Health, University of South Carolina, Columbia, USA
2Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, USA
3Oregon Rural Practice-based Research Network, School of Medicine, Oregon Health & Science University, Portland, USA
4Department of Family Medicine, School of Medicine, Oregon Health & Science University, Portland, USA
5OHSU–PSU School of Public Health, Oregon Health & Science University, Portland, USA
6Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, USA
7Department of Health, Behavior & Society, College of Public Health, University of Kentucky, Lexington, USA
8School of Nursing, Oregon Health & Science University, Portland, USA
9Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA
10Department of Health Services, University of Washington, Seattle, USA
11Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, USA
12Cancer Prevention and Control Program, University of South Carolina, Columbia, USA

Tóm tắt

Rural cancer survivors may disproportionately experience financial problems due to their cancer because of greater travel costs, higher uninsured/underinsured rates, and other factors compared to their urban counterparts. Our objective was to examine rural-urban differences in reported financial problems due to cancer using a nationally representative survey. We used data from three iterations of the National Cancer Institute’s Health Information and National Trends Survey (2012, 2014, and 2017) to identify participants who had a previous or current cancer diagnosis. Our outcome of interest was self-reported financial problems associated with cancer diagnosis and treatment. Rural-urban status was defined using 2003 Rural-Urban Continuum Codes. We calculated weighted percentages and Wald chi-square statistics to assess rural-urban differences in demographic and cancer characteristics. In multivariable logistic regression models, we examined the association between rural-urban status and other factors and financial problems, reporting the corresponding adjusted predicted probabilities. Our sample included 1359 cancer survivors. Rural cancer survivors were more likely to be married, retired, and live in the Midwest or South. Over half (50.5%) of rural cancer survivors reported financial problems due to cancer compared to 38.8% of urban survivors (p = 0.02). This difference was attenuated in multivariable models, 49.3 and 38.7% in rural and urban survivors, respectively (p = 0.06). A higher proportion of rural survivors reported financial problems associated with their cancer diagnosis and treatment compared to urban survivors. Future research should aim to elucidate these disparities and interventions should be tested to address the cancer-related financial problems experienced by rural survivors.

Tài liệu tham khảo

Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289. https://doi.org/10.3322/caac.21349 Yabroff KR, Lund J, Kepka D, Mariotto A (2011) Economic burden of cancer in the US: estimates, projections, and future research. Cancer Epidemiol Biomark Prev 20(10):2006–2014. https://doi.org/10.1158/1055-9965.EPI-11-0650 Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL (2013) Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer 119(20):3710–3717. https://doi.org/10.1002/cncr.28262 Yabroff KR, Dowling EC, Guy GP Jr, Banegas MP, Davidoff A, Han X et al (2016) Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol 34(3):259–267. https://doi.org/10.1200/jco.2015.62.0468 Yabroff KR, Zhao J, Zheng Z, Rai A, Han X (2018) Medical financial hardship among cancer survivors in the United States: what do we know? What do we need to know? Cancer Epidemiol Biomark Prev 27:1389–1397 Wheeler SB, Spencer JC, Pinheiro LC, Carey LA, Olshan AF, Reeder-Haynes KE (2018) Financial impact of breast cancer in black versus white women. J Clin Oncol (36(17)):1695–1701. https://doi.org/10.1200/JCO.2017.77.6310 Palmer NR, Geiger AM, Lu L, Case LD, Weaver KE (2013) Impact of rural residence on forgoing healthcare after cancer because of cost. Cancer Epidemiol Biomark Prev 22(10):1668–1676. https://doi.org/10.1158/1055-9965.epi-13-0421 Charlton M, Schlichting J, Chioreso C, Ward M, Vikas P (2015) Challenges of rural cancer care in the United States. Oncology (Williston Park) 29(9):633–640 McDougall JA, Banegas MP, Wiggins CL, Chiu VK, Rajput A, Kinney AY (2018) Rural disparities in treatment-related financial hardship and adherence to surveillance colonoscopy in diverse colorectal cancer survivors. Cancer Epidemiol Biomark Prev 27(11):1275–1282. https://doi.org/10.1158/1055-9965.epi-17-1083 Mathews M, West R, Buehler S (2009) How important are out-of-pocket costs to rural patients’ cancer care decisions? Can J Rural Med 14(2):54–60 Whitney RL, Bell JF, Reed SC, Lash R, Bold RJ, Kim KK et al (2016) Predictors of financial difficulties and work modifications among cancer survivors in the United States. J Cancer Surviv 10(2):241–250 WeStat (2017) Health Information National Trends Survey 5 (HINTS 5) Cycle 1 Methodology Report July 2017. https://hints.cancer.gov/docs/methodologyreports/HINTS5_Cycle_1_Methodology_Rpt.pdf Accessed 1 October 2018 National Cancer Institute (2018) HINTS Public Use Dataset. Available at https://hints.cancer.gov/data/download-data.aspx Accessed on 1 August 2018 Czajka JL and Beyler A. Declining response rates in federal surveys: trends and implications. https://aspe.hhs.gov/system/files/pdf/255531/Decliningresponserates.pdf. Accessed 23 Sept 2018 United States Department of Agriculture (2016). Rural Urban Continuum Codes. https://www.ers.usda.gov/data-products/rural-urban-continuum-codes. Accessed 1 Aug 2018 Greenberg AJ, Haney D, Blake KD, Moser RP, Hesse BW (2018) Differences in access to and use of electronic personal health information between rural and urban residents in the United States. J Rural Health 34 Suppl 1:s30-s8 doi 10.1111/jrh.12228:s30–s38 National Cancer Institute (2017) Analytics recommendations for HINTS 5, Cycle 1 Data November, 2017. https://hints.cancer.gov/data/download-data.aspx Accessed 1 October 2018 van Buuren S (2007) Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16(3):219–242. https://doi.org/10.1177/0962280206074463 Lee KJ, Carlin JB (2012) Recovery of information from multiple imputation: a simulation study. Emerg Themes Epidemiol 13(9(1)):3. https://doi.org/10.1186/1742-7622-9-3 Graubard BI, Korn EL (1999) Predictive margins with survey data. Biometrics 55(2):652–659 SAS Institute Inc. (2009) SAS/STAT ® 9.2 User’s Guide SEC. SAS Institute Inc, NC, p 2018 Probst JC, Moore CG, Glover SH, Samuels ME (2004) Person and place: the compounding effects of race/ethnicity and rurality on health. Am J Public Health 94(10):1695–1703 Jagsi R, Ward KC, Abrahamse PH, Wallner LP, Kurian AW, Hamilton AS et al (2018) Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer. Cancer 124(18):3668–3676. https://doi.org/10.1002/cncr.31532 Shih YT, Chien CR (2017) A review of cost communication in oncology: patient attitude, provider acceptance, and outcome assessment. Cancer 123(6):928–939. https://doi.org/10.1002/cncr.30423 Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D et al (2009) American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 27(23):3868–3874. https://doi.org/10.1200/JCO.2009.23.1183 Shankaran V, Leahy T, Steelquist J, Watabayashi K, Linden H, Ramsey S et al (2018) Pilot feasibility study of an oncology financial navigation program. J Oncol Pract 14:e122–e129 Zullig LL, Wolf S, Vlastelica L, Shankaran V, Zafar SY (2017) The role of patient financial assistance programs in reducing costs for cancer patients. J Manag Care Spec Pharm 23:407–411 Zafar SY, Chino F, Ubel PA, Rushing C, Samsa G, Altomare I et al (2015) The utility of cost discussions between patients with cancer and oncologists. Am J Manag Care 21(9):607–615 Butow PN, Phillips F, Schweder J, White K, Underhill C, Goldstein D (2012) Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer 20(1):1–22. https://doi.org/10.1007/s00520-011-1270-1 Vanderpool RC, Nichols H, Hoffler EF, Swanberg JE (2017) Cancer and employment issues: perspectives from cancer patient navigators. J Cancer Educ 32(3):460–466. https://doi.org/10.1007/s13187-015-0956-3 Palomino H, Peacher D, Ko E, Woodruff SI, Watson M (2017) Barriers and challenges of cancer patients and their experience with patient navigators in the rural US/Mexico border region. J Cancer Educ 32(1):112–118. https://doi.org/10.1007/s13187-015-0906-0 Inrig SJ, Higashi RT, Tiro JA, Argenbright KE, Lee SJ (2017) Assessing local capacity to expand rural breast cancer screening and patient navigation: an iterative mixed-method tool. Eval Program Plann 61:113–124. https://doi.org/10.1016/j.evalprogplan.2016.11.006 Gordon LG, Merollini KMD, Lowe A, Chan RJ (2017) A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay. Patient 10(3):295–309. https://doi.org/10.1007/s40271-016-0204-x Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML (2011) Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103(2):117–128. https://doi.org/10.1093/jnci/djq495 Shih YT, Smielauskas F, Geynisman DM, Kelly RJ, Smith TJ (2015) Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011. J Clin Oncol 33(19):2190–2196 Tran G, Zafar SY (2018) Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med 6(9):166 Srinivasan S, Moser RP, Willis G, Riley W, Alexander M, Berrigan D et al (2015) Small is essential: importance of subpopulation research in cancer control. Am J Public Health 105(Suppl 3):S371–S373. https://doi.org/10.2105/ajph.2014.302267